Related references
Note: Only part of the references are listed.Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report
Johan Steineger et al.
LARYNGOSCOPE (2018)
Is Bevacizumab Effective for Reducing Epistaxis in Hereditary Hemorrhagic Telangiectasia?
Christopher J. Chin
LARYNGOSCOPE (2017)
Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia A Randomized Clinical Trial
Kevin J. Whitehead et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia A Randomized Clinical Trial
Sophie Dupuis-Girod et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature
Natalia P. Arizmendez et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2015)
Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double-blind, randomized, placebo-controlled trial
Dominik Riss et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
ELLIPSE Study A Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia
S. Dupuis-Girod et al.
MABS (2014)
Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia
Andrew B. Thompson et al.
ALLERGY & RHINOLOGY (2014)
Bevacizumab-Associated Osteonecrosis of the Wrist and Knee in Three Pediatric Patients With Recurrent CNS Tumors
Jason Fangusaro et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Osteonecrosis of the mandible associated with bevacizumab therapy
Alan Roger Santos-Silva et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2013)
A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia
C. Rohrmeier et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2012)
Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output
Sophie Dupuis-Girod et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy
Tom T. Karnezis et al.
LARYNGOSCOPE (2012)
Bevacizumab nasal spray: Noninvasive treatment of epistaxis in patients with rendu-osler disease
Romain Guldmann et al.
LARYNGOSCOPE (2012)
Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: Effectiveness of an injection protocol based on the vascular anatomy of the nose
Sinan Dheyauldeen et al.
LARYNGOSCOPE (2012)
Safety of Intranasal Bevacizumab (Avastin) Treatment in Patients with Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis
Sonia Chen et al.
LARYNGOSCOPE (2011)
Development of an evidence-based review with recommendations using an online iterative process
Luke Rudmik et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
An Epistaxis Severity Score for Hereditary Hemorrhagic Telangiectasia
Jeffrey B. Hoag et al.
LARYNGOSCOPE (2010)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
The Effect of Bevacizumab (Avastin) Treatment on Epistaxis in Hereditary Hemorrhagic Telangiectasia
Jana Simonds et al.
LARYNGOSCOPE (2009)
Anti-vascular endothelial growth factor therapy for ocular neovascular disease
Christopher M. Andreoli et al.
CURRENT OPINION IN OPHTHALMOLOGY (2007)
Classifying recommendations for clinical practice guidelines
CJ Homer et al.
PEDIATRICS (2004)
Health-related quality of life in a rare disease:: Hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber Disease
G Pasculli et al.
QUALITY OF LIFE RESEARCH (2004)
Hereditary haemorrhagic telangiectasia (Osier-Weber-Rendu syndrome): a view from the 21st century
ME Begbie et al.
POSTGRADUATE MEDICAL JOURNAL (2003)
Share Paper
